China is betting on bio-manufacturing to boost technological self-reliance and drive economic growth as part of the next five-year plan, elevating the sector on par with electric vehicles and ...

Fintel reports that on November 20, 2025, Argus Research maintained coverage of Bio-Techne (NasdaqGS:TECH) with a Buy recommendation. As of November 17, 2025, the average one-year price target for Bio ...

Life sciences company Bio-Techne (NASDAQ:TECH) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 1% year on year to $286.6 million. Its non-GAAP profit of $0.42 per share was ...

Michelle Ramos is an artist living in Frederick, but she hasn't always been an artist. It wasn't until a manic episode in 2021 that she found art — and it happened almost overnight. With a bachelor's ...

In a significant boost to Sri Lanka’s agri-tech ambitions, the Lotus Group of Companies has launched the nation’s first private, export-oriented tissue culture laboratory, positioning the island to ...

Europe is one of the global leaders in life sciences, and according to the European Commission, the sector currently adds nearly €1.5tn in value to the economy while supporting 29 million jobs across ...

Hostinger’s link-in-bio builder creates mobile-friendly pages for social media profiles Users can sell products, track engagement, and list up to 600 items with no hidden fees The tool is free, easy ...

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...

SYDNEY, Aug 11 (Reuters) - Shares of China's Ab&B Bio-Tech (2627.HK), opens new tab gained nearly 170% on Monday, as the vaccine development firm debuted on the Hong Kong Stock Exchange after it ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis startup is ...